Timing of futility analyses for ‘proof of concept’ trials
- 7 April 2005
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 24 (12) , 1815-1835
- https://doi.org/10.1002/sim.2087
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Stopping clinical trials because of treatment ineffectiveness: a comparison of a futility design with a method of stochastic curtailmentStatistics in Medicine, 2003
- CONDITIONAL PROBABILITY OF SIGNIFICANCE FOR EARLY STOPPING IN FAVOR OFH0Sequential Analysis, 2002
- ON THE TIMING OF A FUTILITY ANALYSIS IN CLINICAL TRIALSJournal of Biopharmaceutical Statistics, 2000
- Sample size determination: a reviewJournal of the Royal Statistical Society: Series D (The Statistician), 1997
- Perspective: Validating Surrogate Markers--Are We Being Naive?The Journal of Infectious Diseases, 1997
- Surrogate End Points in Clinical Trials: Are We Being Misled?Annals of Internal Medicine, 1996
- Monitoring versus interim analysis of clinical trials: A perspective from the pharmaceutical industryControlled Clinical Trials, 1989
- Monitoring clinical trials: Conditional or predictive power?Controlled Clinical Trials, 1986
- “Proving the null hypothesis” in clinical trialsControlled Clinical Trials, 1982
- Statistical Prediction AnalysisPublished by Cambridge University Press (CUP) ,1975